Kendra Triplett
Publications by Year
Research Areas
Complement system in diseases, Monoclonal and Polyclonal Antibodies Research, Tryptophan and brain disorders, Cancer Immunotherapy and Biomarkers, Galectins and Cancer Biology
Most-Cited Works
- → Systemic depletion of L-cyst(e)ine with cyst(e)inase increases reactive oxygen species and suppresses tumor growth(2016)530 cited
- → Oncogene-Selective Sensitivity to Synchronous Cell Death following Modulation of the Amino Acid Nutrient Cystine(2017)286 cited
- → IgG Fc domains that bind C1q but not effector Fcγ receptors delineate the importance of complement-mediated effector functions(2017)143 cited
- → STAT3 Signaling Is Required for Optimal Regression of Large Established Tumors in Mice Treated with Anti-OX40 and TGFβ Receptor Blockade(2015)20 cited
- → Abstract 5570: A novel approach to targeting the IDO/TDO pathway through degradation of the immunosuppressive metabolite kynurenine(2017)7 cited
- → Erratum: Corrigendum: IgG Fc domains that bind C1q but not effector Fcγ receptors delineate the importance of complement-mediated effector functions(2017)7 cited
- → Abstract LB-226: Depletion of kynurenine using an engineered therapeutic enzyme potently inhibits cancer immune checkpoints both as a monotherapy and in combination with anti-PD-1(2015)5 cited
- → Abstract 5571: Immune-checkpoint inhibition via enzyme-mediated degradation of kynurenine(2017)2 cited
- IgG Fc Domains that Bind C1q but not Effector Fc? Receptors Delineate the Significance of Complement- Mediated Cell Cytotoxicity and Phagocytosis in Antibody Function(2018)